In spite of all the advances in pharmaceuticals and medical devices, 300,000 patients in the U.S. die every year from end stage heart failure and 250,000 heart failure patients lack a viable treatment option.

NeoCardial Technologies™ is dedicated to helping this underserved patient group lead a normal, healthy and long life.

Introducing eHeart™ designed to offer new treatment options for patients with chronic heart failure who are no longer responding to standard medical care.